Cargando…
2199. Antiviral Therapy Use in Hepatitis B-Infected Pregnant Women
BACKGROUND: Perinatal Hepatitis B Virus (HBV) transmission results in chronic disease in 90% of infected infants. Immunoprophylaxis reduces perinatal HBV infections by 95%. For women with viral loads >200,000 IU/mL, antiviral therapy during pregnancy is recommended to further reduce perinatal tra...
Autores principales: | Schillie, Sarah, Nelson, Noele, Lazaroff, Julie, Burkhardt, Elizabeth, Fineis, Patrick, Born, Sarah, Hinds, Deborah, Koneru, Alaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254268/ http://dx.doi.org/10.1093/ofid/ofy210.1853 |
Ejemplares similares
-
Antiviral Treatment among Hepatitis B Virus-Infected Pregnant Women—New York City and Michigan, 2013–2015
por: Link-Gelles, Ruth, et al.
Publicado: (2017) -
Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
por: Fan, Lin, et al.
Publicado: (2014) -
Prevention of Hepatitis A Virus Infection in the United States:
Recommendations of the Advisory Committee on Immunization Practices, 2020
por: Nelson, Noele P., et al.
Publicado: (2020) -
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
por: Schillie, Sarah, et al.
Publicado: (2018) -
Prevention of Hepatitis B Virus Infection in the United States:
Recommendations of the Advisory Committee on Immunization
Practices
por: Schillie, Sarah, et al.
Publicado: (2018)